— Know what they know.
Not Investment Advice
Also trades as: EYE.AX (ASX) · $vol 0M

ELXMF OTC

Nova Eye Medical Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +653.2% 1Y: -85.7% 3Y: -85.7% 5Y: -94.5%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 48 · $4.1M mcap · 233M float · 0.0004% daily turnover · Short 100% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
5
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ELXMF receives an overall rating of C. Strongest factors: P/B (5/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-03 None ADDED
2026-10-03 EXISTED None
2026-09-29 None ADDED
2026-09-27 EXISTED None
2026-09-23 None ADDED
2026-09-23 EXISTED None
2026-09-19 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-13 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
43
Growth
88
Value
—
Momentum
80
Safety
—
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗ ✓
Beneish M-Score
-3.13
Unlikely Manipulator
Ohlson O-Score
-2.45
Bankruptcy prob: 8.0%
Low Risk
Credit Rating
BB+
Score: 46.8/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.69x
Accruals: -16.0%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ELXMF scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ELXMF's score of -3.13 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ELXMF's implied 8.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ELXMF receives an estimated rating of BB+ (score: 46.8/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-8.55x
PEG
-0.10x
P/S
1.06x
P/B
2.59x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ELXMF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.002
EBT / EBIT
×
EBIT Margin
-0.208
EBIT / Rev
×
Asset Turnover
2.492
Rev / Assets
×
Equity Multiplier
1.446
Assets / Equity
=
ROE
-75.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ELXMF's ROE of -75.3% is driven by Asset Turnover (2.492), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.01
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
413.8%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
ROE 10.1% 4.4% -2.9% -9.8% -16.8% -19.3% -16.9% -16.2% -21.5% -21.8% -23.5% -18.1% -54.4% -77.9% -99.1% -93.1% -1.1% -84.7% -94.9% -75.3% -75.25%
ROA 6.8% 2.9% -2.1% -6.8% -11.5% -13.0% -11.9% -12.8% -14.9% -16.0% -17.2% -15.5% -40.8% -63.0% -81.1% -72.4% -80.6% -62.8% -65.6% -52.1% -52.06%
ROIC 12.4% 8.5% 1.8% -4.4% -13.4% -13.6% -16.3% -1.5% -92.1% -47.8% -47.7% -49.7% -64.5% -97.1% -1.1% -76.9% -58.9% -50.8% -38.2% -44.7% -44.71%
ROCE 15.0% 10.3% 2.2% -4.0% -15.0% -16.0% -19.7% -14.6% -28.6% -30.1% -29.8% -36.8% -64.7% -81.4% -1.3% -83.7% -92.3% -82.9% -86.7% -83.3% -83.30%
Gross Margin 59.4% 54.8% 55.7% 60.9% 79.5% 17.5% -7.3% -20.5% 12.5% 13.9% -3.2% -8.1% -7.0% 16.5% 13.0% 85.4% 66.2% 63.2% 70.1% 73.2% 73.23%
Operating Margin 6.8% -6.6% -4.1% -4.8% -70.0% -7.2% -48.6% -66.8% -40.4% -44.3% -68.5% -75.3% -83.5% -53.6% -55.3% -6.0% -21.4% -10.6% -20.8% -5.0% -4.96%
Net Margin 2.9% -5.1% -7.1% -5.7% -51.6% -7.7% -36.1% -80.7% -24.2% -40.8% -47.0% -64.6% -78.7% -1.0% -55.5% -24.0% -41.7% -22.4% -20.1% -5.3% -5.33%
EBITDA Margin 10.8% -5.9% 0.4% -3.9% -63.2% -0.7% -38.9% -53.9% -12.3% -24.8% -33.6% -59.0% -70.2% -38.9% -41.3% -11.7% -40.1% -9.4% -14.1% 0.9% 0.85%
FCF Margin -0.1% -7.2% -10.3% -8.4% -9.4% -6.5% -6.1% -3.9% -6.8% -43.4% -65.9% -94.9% -93.2% -58.5% -50.4% -39.0% -31.9% -27.9% -21.3% -15.3% -15.29%
OCF Margin 6.6% 1.2% -1.3% -2.0% -3.5% -2.8% -1.3% 2.2% 0.1% -28.5% -39.8% -65.7% -67.2% -37.5% -43.4% -36.0% -30.1% -26.5% -20.5% -14.5% -14.46%
ROE 3Y Avg snapshot only -81.94%
ROE 5Y Avg snapshot only -53.59%
ROA 3Y Avg snapshot only -58.35%
ROIC 3Y Avg snapshot only -49.94%
ROIC Economic snapshot only -44.71%
Cash ROA snapshot only -43.00%
Cash ROIC snapshot only -59.11%
CROIC snapshot only -62.51%
NOPAT Margin snapshot only -10.94%
Pretax Margin snapshot only -20.89%
R&D / Revenue snapshot only 9.31%
SGA / Revenue snapshot only 72.99%
SBC / Revenue snapshot only 0.14%
Valuation
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — -8.553
P/S Ratio — — — — — — — — — — — — — — — — — — — — 1.062
P/B Ratio — — — — — — — — — — — — — — — — — — — — 2.594
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
Leverage & Solvency
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Current Ratio 2.66 1.72 3.11 2.71 1.95 1.97 2.50 7.17 2.94 5.62 6.75 4.04 2.49 2.33 1.47 2.60 1.84 2.39 1.85 1.74 1.740
Quick Ratio 1.45 0.89 2.04 1.72 1.14 1.08 2.40 6.96 2.68 5.00 5.53 3.12 1.64 1.72 0.81 1.84 1.04 1.85 1.24 1.15 1.154
Debt/Equity 0.18 0.27 0.20 0.20 0.21 0.22 0.03 0.03 0.09 0.10 0.06 0.06 0.07 0.07 0.07 0.16 0.19 0.16 0.31 0.17 0.168
Net Debt/Equity -0.06 0.11 -0.13 -0.11 -0.06 -0.00 0.02 -0.92 -0.71 -0.40 -0.33 -0.20 -0.03 -0.25 -0.08 -0.13 0.06 -0.11 0.15 0.10 0.100
Debt/Assets 0.12 0.18 0.15 0.14 0.15 0.15 0.02 0.03 0.06 0.09 0.05 0.05 0.06 0.05 0.05 0.11 0.13 0.11 0.21 0.11 0.111
Debt/EBITDA 0.61 1.17 1.63 119.99 -1.80 -2.28 -0.20 -0.31 -0.48 -0.45 -0.27 -0.22 -0.13 -0.10 -0.07 -0.22 -0.24 -0.24 -0.46 -0.27 -0.268
Net Debt/EBITDA -0.20 0.48 -1.03 -64.54 0.51 0.04 -0.13 8.46 3.82 1.71 1.50 0.69 0.06 0.38 0.08 0.19 -0.08 0.16 -0.22 -0.16 -0.160
Interest Coverage — — — — — -44.60 -46.98 -47.36 -31.53 -85.58 -80.08 -91.30 -141.03 -166.04 -228.39 -163.39 -180.98 -122.90 -77.45 -58.62 -58.623
Equity Multiplier 1.45 1.52 1.37 1.41 1.47 1.45 1.49 1.16 1.39 1.19 1.13 1.20 1.25 1.31 1.40 1.40 1.48 1.40 1.50 1.51 1.512
Cash Ratio snapshot only 0.174
Debt Service Coverage snapshot only -39.193
Cash to Debt snapshot only 0.403
FCF to Debt snapshot only -4.100
Defensive Interval snapshot only 42.0 days
Efficiency & Turnover
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Asset Turnover 1.95 1.99 1.80 1.72 1.30 1.36 0.95 0.55 0.76 0.37 0.37 0.35 0.69 0.84 1.09 1.21 1.58 1.85 2.49 2.49 2.492
Inventory Turnover 3.00 3.17 3.36 3.11 2.05 2.73 4.64 3.86 3.65 1.80 7.75 7.96 8.62 9.04 8.58 6.88 5.70 6.38 4.54 5.38 5.378
Receivables Turnover 11.25 10.78 10.32 10.15 8.33 8.42 10.56 7.44 5.80 3.03 12.29 26.60 8.59 15.84 16.30 19.10 16.73 17.47 18.79 14.39 14.395
Payables Turnover 7.31 15.80 9.05 17.04 5.44 11.51 13.58 16.17 8.79 5.50 20.34 8.27 11.22 9.61 11.71 9.02 8.38 6.34 5.12 6.68 6.681
DSO 32 34 35 36 44 43 35 49 63 120 30 14 43 23 22 19 22 21 19 25 25.4 days
DIO 122 115 109 117 178 134 79 95 100 203 47 46 42 40 43 53 64 57 80 68 67.9 days
DPO 50 23 40 21 67 32 27 23 42 66 18 44 33 38 31 40 44 58 71 55 54.6 days
Cash Conversion Cycle 104 126 104 132 154 145 86 121 122 257 59 15 52 25 34 32 42 21 29 39 38.6 days
Fixed Asset Turnover snapshot only 24.361
Operating Cycle snapshot only 93.2 days
Cash Velocity snapshot only 66.587
Capital Intensity snapshot only 0.336
Growth (YoY)
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue 32.0% 23.6% 17.1% 11.4% -11.4% -12.2% -34.9% -60.0% -52.1% -79.4% -73.8% -55.7% -52.0% 16.2% 34.5% 50.7% 57.4% 73.0% 74.0% 58.9% 58.86%
Net Income 6.6% -13.6% -1.5% -2.3% -3.2% -6.7% -5.9% -1.4% -6.5% 6.4% 2.9% 15.6% -44.4% -1.0% -1.2% -1.0% -35.7% 21.7% 38.5% 44.4% 44.40%
EPS 6.2% -23.6% -1.5% -2.0% -2.8% -5.8% -4.9% -1.3% -3.7% 9.0% 3.5% 16.8% -42.3% -75.2% -63.5% -39.6% 11.5% 50.0% 57.7% 57.5% 57.53%
FCF -1.0% -2.5% -2.8% -3.3% -114.1% 21.0% 61.1% 81.5% 65.0% -37.3% -1.8% -9.8% -5.5% -56.9% -2.9% 38.0% 46.1% 17.5% 26.4% 37.8% 37.76%
EBITDA 2.4% 90.4% 1.8% -99.2% -1.5% -1.5% -2.0% -88.3% 19.8% -24.9% 21.6% 20.0% -1.0% -87.5% -1.3% -71.6% -3.4% 19.6% 39.2% 40.4% 40.36%
Op. Income 2.4% 11.4% -75.8% -1.4% -2.1% -3.1% -10.1% -3.3% -11.9% -8.9% 1.0% 1.0% -54.1% -65.5% -63.1% -17.8% 29.7% 48.8% 60.9% 50.8% 50.76%
OCF Growth snapshot only 36.19%
Asset Growth snapshot only -27.86%
Equity Growth snapshot only -33.17%
Debt Growth snapshot only -28.62%
Shares Change snapshot only 30.91%
Growth (CAGR)
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue 3Y 79.3% 46.9% 30.0% 18.4% 11.7% 12.8% 1.3% -14.7% -17.6% -39.3% -41.5% -41.8% -41.2% -40.6% -38.8% -35.6% -28.7% -25.5% -15.0% 1.9% 1.95%
Revenue 5Y — — — — — — — — 19.6% -10.6% -17.8% -21.7% -20.4% -19.2% -18.2% -16.2% -15.8% -14.8% -14.1% -13.9% -13.94%
EPS 3Y 23.6% -0.7% — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y 36.9% 11.7% — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y 75.7% 53.1% 29.8% -72.2% — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 79.7% 50.6% 34.1% 23.5% 18.5% 11.0% -6.4% -38.3% -51.5% -87.1% -81.0% -76.3% — -90.2% -73.3% -46.4% -32.3% -19.1% 3.6% 56.2% 56.24%
Gross Profit 5Y — — — — — — — — -14.6% -64.9% -57.9% -53.6% — -71.8% -48.9% -22.8% -16.1% -12.3% -9.1% -10.1% -10.14%
Op. Income 3Y 72.5% 56.0% 6.0% — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y 57.6% -11.0% — — — — — -34.2% -74.7% — — — — — — — — — — — —
OCF 5Y — — — — — — — — -48.0% — — — — — — — — — — — —
Assets 3Y 18.5% 18.8% 29.6% 32.1% 33.3% 28.3% 24.0% 29.1% -3.8% -10.7% -13.3% -20.2% -28.7% -29.5% -39.0% -33.9% -37.6% -35.7% -37.8% -43.1% -43.05%
Assets 5Y — — — — — — — — 0.0% -4.0% -4.4% -4.0% -7.0% -8.5% -14.3% -11.2% -15.0% -14.8% -16.8% -21.4% -21.43%
Equity 3Y 21.4% 19.9% 36.7% 31.7% 31.4% 30.7% 21.5% 39.6% -1.0% -3.9% -6.2% -14.3% -25.1% -25.9% -39.5% -33.7% -37.6% -34.9% -37.9% -47.9% -47.86%
Book Value 3Y 9.6% 6.6% 20.0% 10.6% 10.3% 9.7% 9.7% 25.3% -10.6% -13.7% -15.6% -22.6% -31.3% -33.8% -47.9% -42.3% -46.7% -46.9% -50.1% -58.1% -58.14%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue Stability 0.94 0.99 0.99 0.93 0.66 0.62 0.03 0.09 0.18 0.00 0.06 0.26 0.33 0.33 0.43 0.46 0.64 0.54 0.60 0.52 0.520
Earnings Stability 0.32 0.20 0.12 0.27 0.30 0.40 0.56 0.63 0.54 0.60 0.71 0.71 0.72 0.78 0.84 0.84 0.88 0.82 0.75 0.63 0.634
Margin Stability 0.93 0.94 0.94 0.93 0.92 0.91 0.85 0.61 0.56 0.44 0.44 0.35 0.19 0.09 0.16 0.32 0.19 0.09 0.11 0.27 0.269
Rev. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.99 0.94 0.82 0.50 0.50 0.50 0.86 0.91 0.85 0.82 0.822
Earnings Smoothness 0.00 0.85 — — — — — — — — — — — — — — — — — — —
ROE Trend 0.08 0.02 -0.06 -0.13 -0.20 -0.23 -0.21 -0.15 -0.28 -0.25 -0.24 -0.28 -0.44 -0.73 -1.22 -0.86 -0.82 -0.29 -0.07 -0.18 -0.180
Gross Margin Trend 0.06 0.07 0.05 0.05 0.05 -0.08 -0.16 -0.37 -0.47 -0.52 -0.46 -0.35 -0.36 -0.23 -0.16 0.22 0.46 0.59 0.67 0.50 0.499
FCF Margin Trend -0.02 -0.11 -0.15 -0.12 -0.11 -0.06 -0.04 -0.02 -0.02 -0.36 -0.58 -0.89 -0.85 -0.34 -0.14 0.10 0.18 0.23 0.37 0.52 0.517
Sustainable Growth Rate 10.1% 4.4% — — — — — — — — — — — — — — — — — — —
Internal Growth Rate 7.3% 3.0% — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 1.88 0.81 1.07 0.50 0.40 0.30 0.10 -0.09 -0.01 0.66 0.86 1.48 1.14 0.50 0.58 0.60 0.59 0.78 0.78 0.69 0.692
FCF/OCF -0.01 -6.08 8.16 4.26 2.64 2.29 4.74 -1.77 -45.70 1.52 1.65 1.44 1.39 1.56 1.16 1.08 1.06 1.05 1.04 1.06 1.057
FCF/Net Income snapshot only 0.732
CapEx/Revenue 6.6% 8.4% 9.0% 6.4% 5.8% 3.7% 4.8% 6.1% 7.0% 14.9% 26.1% 29.2% 26.0% 21.0% 7.0% 2.9% 1.7% 1.3% 0.8% 0.8% 0.83%
CapEx/Depreciation snapshot only 0.120
Accruals Ratio -0.06 0.01 0.00 -0.03 -0.07 -0.09 -0.11 -0.14 -0.15 -0.05 -0.02 0.07 0.06 -0.31 -0.34 -0.29 -0.33 -0.14 -0.15 -0.16 -0.160
Sloan Accruals snapshot only -0.366
Cash Flow Adequacy snapshot only -17.398
Dividends & Buybacks
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.13 $0.13 $0.13 $0.13 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio 0.0% 0.0% — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — 0 0 0 0 — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 0.69 0.96 0.74 0.84 0.79 0.93 0.88 0.93 1.02 0.91 0.98 0.88 0.89 0.90 0.91 0.93 0.95 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.71 0.37 -1.25 2.20 1.26 1.16 1.04 1.01 1.03 1.11 1.12 1.12 1.08 1.29 1.25 1.27 1.30 1.01 1.00 1.00 1.002
EBIT Margin 0.07 0.04 0.01 -0.02 -0.09 -0.09 -0.14 -0.25 -0.19 -0.43 -0.42 -0.45 -0.61 -0.64 -0.65 -0.50 -0.42 -0.34 -0.26 -0.21 -0.208
Asset Turnover 1.95 1.99 1.80 1.72 1.30 1.36 0.95 0.55 0.76 0.37 0.37 0.35 0.69 0.84 1.09 1.21 1.58 1.85 2.49 2.49 2.492
Equity Multiplier 1.48 1.50 1.39 1.44 1.46 1.48 1.42 1.27 1.44 1.36 1.37 1.17 1.34 1.24 1.22 1.29 1.34 1.35 1.45 1.45 1.446
Per Share
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $0.04 $0.02 $-0.01 $-0.04 $-0.08 $-0.08 $-0.08 $-0.10 $-0.08 $-0.08 $-0.08 $-0.08 $-0.11 $-0.13 $-0.13 $-0.11 $-0.10 $-0.07 $-0.05 $-0.05 $-0.05
Book Value/Share $0.51 $0.47 $0.61 $0.51 $0.50 $0.48 $0.45 $0.68 $0.25 $0.24 $0.23 $0.20 $0.17 $0.14 $0.09 $0.10 $0.08 $0.07 $0.06 $0.05 $0.05
Tangible Book/Share $0.48 $0.44 $0.58 $0.48 $0.47 $0.45 $0.42 $0.61 $0.23 $0.16 $0.18 $0.08 $0.12 $0.06 $0.05 $0.07 $0.04 $0.05 $0.02 $0.02 $0.02
Revenue/Share $1.21 $1.20 $1.18 $1.05 $0.86 $0.89 $0.65 $0.41 $0.40 $0.18 $0.17 $0.18 $0.19 $0.18 $0.17 $0.19 $0.20 $0.20 $0.21 $0.23 $0.12
FCF/Share $-0.00 $-0.09 $-0.12 $-0.09 $-0.08 $-0.06 $-0.04 $-0.02 $-0.03 $-0.08 $-0.11 $-0.17 $-0.18 $-0.11 $-0.09 $-0.07 $-0.06 $-0.06 $-0.04 $-0.03 $-0.01
OCF/Share $0.08 $0.01 $-0.01 $-0.02 $-0.03 $-0.03 $-0.01 $0.01 $0.00 $-0.05 $-0.07 $-0.12 $-0.13 $-0.07 $-0.08 $-0.07 $-0.06 $-0.05 $-0.04 $-0.03 $-0.01
Cash/Share $0.12 $0.08 $0.20 $0.16 $0.14 $0.11 $0.00 $0.65 $0.20 $0.12 $0.09 $0.05 $0.02 $0.04 $0.01 $0.03 $0.01 $0.02 $0.01 $0.00 $0.00
EBITDA/Share $0.15 $0.11 $0.08 $0.00 $-0.06 $-0.05 $-0.07 $-0.07 $-0.05 $-0.06 $-0.05 $-0.06 $-0.09 $-0.09 $-0.09 $-0.07 $-0.06 $-0.05 $-0.04 $-0.03 $-0.03
Debt/Share $0.09 $0.13 $0.12 $0.10 $0.11 $0.11 $0.01 $0.02 $0.02 $0.03 $0.01 $0.01 $0.01 $0.01 $0.01 $0.02 $0.01 $0.01 $0.02 $0.01 $0.01
Net Debt/Share $-0.03 $0.05 $-0.08 $-0.06 $-0.03 $-0.00 $0.01 $-0.63 $-0.18 $-0.10 $-0.08 $-0.04 $-0.01 $-0.03 $-0.01 $-0.01 $0.00 $-0.01 $0.01 $0.01 $0.01
Academic Models
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 7 4 1 3 2 3 2 4 4 3 3 1 1 4 4 3 3 5 5 4 4
Beneish M-Score -2.60 -2.34 -2.24 -2.74 0.05 -1.60 -8.66 -5.23 -1.79 -3.69 -2.19 -0.30 -3.28 -4.50 -5.12 -3.85 -4.87 -2.90 -2.98 -3.13 -3.131
Ohlson O-Score snapshot only -2.446
ROIC (Greenblatt) snapshot only -1.99%
Net-Net WC snapshot only $0.01
EVA snapshot only $-8580632.39
Credit
Metric Trend Q2'17 Q4'17 Q2'18 Q4'18 Q2'19 Q4'19 Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only BB+
Credit Score 75.15 66.80 71.00 49.95 55.80 45.80 49.65 53.40 51.15 51.00 51.00 51.00 49.05 49.05 44.25 49.95 46.80 49.05 45.80 46.80 46.800
Credit Grade snapshot only 11
Credit Trend snapshot only -3.150
Implied Spread (bps) snapshot only 400.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms